A study from University of Bordeaux, France has reported that “miR-92a regulates expression of synaptic GluA1-containing AMPA receptors during homeostatic scaling.”
This study was published in the July 13, 2014 Nature Neuroscience [I.F >15] by Prof. Favereaux A, Letellier M and others from University of Bordeaux, France.
On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Epigallocatechin 3-Gallate (EGCG), the major component of green tea, increases the expression of excitatory neurotransmitter Glutamate receptor-1 (GluA1/Gria1) via down regulation of its target gene. This study may suggest that Epigallocatechin 3-Gallate, by down regulating its target gene, it may increase excitatory neurotransmitter responses.
Idea Proposed/Formulated by: Dr L Boominathan PhD
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Courtesy: When you cite drop us a line at info@genomediscovery.org
Citation: Boominathan, Epigallocatechin 3-Gallate (EGCG), the major component of green tea, increases the expression of excitatory neurotransmitter Glutamate receptor-1 (GluA1/Gria1) via down regulation of its target gene, 22/July/2014, 7.34 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Web: http://genomediscovery.org
*Research cooperation